Cyclospora infections, once considered a tropical disease, have garnered global attention due to the increasing recognition of its prevalence and impact on public health. The parasite's ability to contaminate food and water sources, coupled with international food trade, has led to the emergence of Cyclospora as a significant foodborne pathogen in various regions. Surveillance and epidemiological investigations play a pivotal role in understanding the distribution and patterns of Cyclospora infections. The globalization of food supply chains has heightened the need for international cooperation to track and manage outbreaks effectively. Collaborative efforts involve sharing information on contaminated products, implementing preventive measures, and improving food safety standards. The challenge in addressing Cyclospora infections lies in the resilient nature of its oocysts, which can withstand routine washing and disinfection processes. Consequently, research focuses on developing innovative methods for detecting and eliminating Cyclospora in the food production and distribution chain. This includes exploring technologies for water treatment, refining agricultural practices, and enhancing surveillance capabilities to prevent and control outbreaks. Public health responses to Cyclospora infections involve a combination of regulatory measures, consumer education, and industry collaboration. Rigorous food safety regulations, including traceability and monitoring systems, contribute to preventing the spread of Cyclospora through contaminated produce. Additionally, raising awareness among healthcare professionals and the general public about the risk factors, symptoms, and preventive measures is crucial for early detection and intervention.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain